Strategic collaboration in health research and innovation between EU and China (CSA Coordination and support action) - SC1-HCO-11-2018

Date de clôture : 18 avr. 2018  
APPEL À PROJET CLÔTURÉ

Compared to its size and increasing weight on the R&I international scene, China's participation and cooperation to the Horizon 2020 SC1 programmes is low. This is a lost opportunity because most of the major health challenges are global, and cooperation with China on specific strategic health challenges can contribute to provide more evidence-based solutions and to avoid duplication.

The objective of this action is to support networking between European and Chinese policy makers, programme owners and funders, with the following goals:

1. To develop a sustainable platform between EU and China that will facilitate a constant dialogue on addressing common health R&I challenges.
2. To identify health challenges, whose solution may benefit from closer bi-lateral and/or multi-lateral cooperation between EU and China, to facilitate and develop collaborative research initiatives between EU and Chinese stakeholders.

The Commission considers that a proposal requesting an EU contribution between EUR 0.8 and 1 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

• Increased bi-lateral and multi-lateral cooperation on health research strategic items between EU and China.
• Higher participation of Chinese researchers in SC1 and future EU health research programmes, but also of European researchers in Chinese health research programmes.

International cooperation